Live Chat

News

Dolomite Bio’s Nadia and PacBio’s Sequel system demonstrate the ability to perform Single cell isoform sequencing to identify novel full-length mRNAs15th March 2019

In his AGBT 2019 presentation, PacBio’s Jason Underwood shared results of a collaborative project using Dolomite Bio’s Nadia Instrument together with the PacBio Sequel System for single cell isoform sequencing.

read more

Dolomite Bio’s Nadia and PacBio’s Sequel system demonstrate the ability to perform Single cell isoform sequencing to identify novel full-length mRNAs
Product Notice: µEncapsulator system to transfer to Dolomite Microfluidics11th March 2019

Dolomite Bio has decided to transfer the µencapsulator system to their sister brand, Dolomite Microfluidics - an expert in microfluidic technology. This decision enables Dolomite Bio to have an enhanced commercial focus on their newest product range - the Nadia Product family.

read more

Product Notice: µEncapsulator system to transfer to Dolomite Microfluidics
Dolomite Bio unveils new scRNA-Seq Reagent Kit at AGBT2019™27th February 2019

Dolomite Bio, a leading provider of cutting-edge single cell technologies, today announced the launch of a new scRNA-Seq Reagent Kit to expand the Nadia Instrument portfolio. This convenient and cost-effective option is being showcased at the Advances in Genome Biology and Technology 2019 General Meeting (AGBT2019) – February 27th to March 2nd in Marco Island, Florida.

read more

Dolomite Bio unveils new scRNA-Seq Reagent Kit at AGBT2019™
Discontinuation notice: scRNA-Seq modular system30th January 2019

After careful consideration, Dolomite Bio have decided to discontinue the manufacture and sales of the scRNA-Seq modular system. Dolomite Bio will be accepting orders of the scRNA-Seq modular system up until 30th June 2019 and will supply parts to current users until 30th June 2024.

read more

Discontinuation notice:  scRNA-Seq modular system
Dolomite Bio continues rapid growth trajectory and novel product developments throughout 201816th January 2019

Dolomite Bio, part of the Blacktrace group, is helping to drive forward the single cell genomics revolution. Single cell analysis promises to transform drug discovery and disease research, enabling scientists to investigate cell diversity and quantify gene expression at the cellular level. 

read more

Dolomite Bio continues rapid growth trajectory and novel product developments throughout 2018